2026-2034年全球骨關節炎治療市場規模、佔有率、趨勢和成長分析報告

預計骨關節炎治療市場規模將從 2025 年的 116.4 億美元成長到 2034 年的 250.5 億美元，2026 年至 2034 年的複合年成長率為 8.89%。

由於人口老化導致關節疾病發生率不斷上升，全球骨關節炎治療市場正在不斷擴大。骨關節炎是全球最常見的肌肉骨骼疾病之一。肥胖率上升和久坐的生活方式加劇了疾病的流行。人們對有效緩解疼痛和提高生活品質的需求正在推動藥物研發。

目前的治療方法包括止痛藥、消炎藥和注射療法。製藥公司正在投資研發針對軟骨退化根本原因的緩解疾病藥物。醫療保健支出的成長和診斷能力的提高正在推動市場成長。新興市場治療途徑的擴大進一步擴大了患者群體。

未來前景取決於創新治療方法的成功研發。生物製藥和再生醫學的進步有望徹底改變治療方法。公眾意識的提高和早期診斷的普及將推動對治療方案的需求。隨著全球人口老化，骨關節炎治療市場預計將保持穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球骨關節炎治療市場：依藥物類別分類

• 市場分析、洞察與預測
• 皮質類固醇
• 非類固醇消炎劑（NSAIDs）及其他
• 黏彈性補充劑

第5章 全球骨關節炎治療市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 腸外
• 局部的

第6章 全球骨關節炎治療市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球骨關節炎治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Horizon Pharma Plc
  • Pfizer Inc
  • Sanofi
  • Anika Therapeutics Inc
  • Ferring BV
  • Bioventus Inc
  • Chugai Pharmaceutical Co. Ltd
  • Alkem Laboratories
  • Flexion Therapeutics Inc
  • Zimmer Biomet Holdings Inc

The Osteoarthritis Drug Market size is expected to reach USD 25.05 Billion in 2034 from USD 11.64 Billion (2025) growing at a CAGR of 8.89% during 2026-2034.

The Global Osteoarthritis Drug Market is expanding due to the rising prevalence of joint disorders among aging populations. Osteoarthritis is one of the most common musculoskeletal conditions worldwide. Increasing obesity rates and sedentary lifestyles contribute to disease incidence. Demand for effective pain management and improved quality of life drives pharmaceutical development.

Current treatments include analgesics, anti-inflammatory drugs, and injectable therapies. Pharmaceutical companies are investing in research for disease-modifying drugs that target underlying cartilage degeneration. Growing healthcare expenditure and improved diagnostic capabilities support market growth. Access to treatment in emerging markets further expands patient reach.

Future prospects depend on successful development of innovative therapies. Advances in biologics and regenerative medicine may transform treatment approaches. Increased awareness and early diagnosis will drive demand for therapeutic solutions. As the global population ages, the osteoarthritis drug market is expected to sustain steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Class

• Corticosteroids
• NSAIDs and Others
• Viscosupplementation Agents

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Horizon Pharma plc, Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring BV, Bioventus Inc, Chugai Pharmaceutical Co Ltd, Alkem Laboratories, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. NSAIDs and Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Viscosupplementation Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Class
  • 7.2.2 By Route Of Administration
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Class
  • 7.3.2 By Route Of Administration
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Class
  • 7.4.2 By Route Of Administration
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Class
  • 7.5.2 By Route Of Administration
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Class
  • 7.6.2 By Route Of Administration
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OSTEOARTHRITIS DRUG INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Horizon Pharma Plc
  • 9.2.2 Pfizer Inc
  • 9.2.3 Sanofi
  • 9.2.4 Anika Therapeutics Inc
  • 9.2.5 Ferring B.V
  • 9.2.6 Bioventus Inc
  • 9.2.7 Chugai Pharmaceutical Co. Ltd
  • 9.2.8 Alkem Laboratories
  • 9.2.9 Flexion Therapeutics Inc
  • 9.2.10 Zimmer Biomet Holdings Inc